Glycosylated fibronectin improves first-trimester prediction of pre-eclampsia

被引:6
作者
Moungmaithong, S. [1 ]
Wang, X. [2 ]
Lau, C. S. L. [2 ]
Tse, A. W. T. [3 ]
Lee, N. M. W.
Leung, H. H. Y. [2 ]
Poon, L. C. [2 ,4 ,5 ]
Sahota, D. S. [2 ,4 ,5 ]
机构
[1] Mahidol Univ, Siriraj Hosp, Dept Obstet & Gynaecol, Bangkok, Thailand
[2] Chinese Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Peoples R China
[3] Prince Wales Hosp, Dept Obstet & Gynaecol, Shatin, Hong Kong, Peoples R China
[4] Chinese Univ Hong Kong, Shenzhen Res Inst, Hong Kong, Peoples R China
[5] Chinese Univ Hong Kong, Hong Kong, Peoples R China
关键词
competing-risks model; endothelial biomarker; Fetal Medicine Foundation; first-trimester screening; glycosylated fibronectin; mean arterial pressure; placental growth factor; PlGF; point-of-care device; pre-eclampsia; uterine artery Doppler;
D O I
10.1002/uog.27451
中图分类号
O42 [声学];
学科分类号
070206 ; 082403 ;
摘要
Objective To determine whether maternal serum glycosylated fibronectin (GlyFn) level in the first trimester increases the sensitivity of the Fetal Medicine Foundation (FMF) triple test, which incorporates mean arterial pressure, uterine artery pulsatility index and placental growth factor, when screening for pre-eclampsia (PE) in an Asian population.Methods This was a nested case-control study of Chinese women with a singleton pregnancy who were screened for PE at 11-13 weeks' gestation as part of a non-intervention study between December 2016 and June 2018. GlyFn levels were measured retrospectively in archived serum from 1685 pregnancies, including 101 with PE, using an enzyme-linked immunosorbent assay (ELISA), and from 448 pregnancies, including 101 with PE, using a point-of-care (POC) device. Concordance between ELISA and POC tests was assessed using Lin's correlation coefficient and Passing-Bablok and Bland-Altman analyses. GlyFn was transformed into multiples of the median (MoM) to adjust for maternal and pregnancy characteristics. GlyFn MoM was compared between PE and non-PE pregnancies, and the association between GlyFn MoM and gestational age at delivery with PE was assessed. Risk for developing PE was estimated using the FMF competing-risks model. Screening performance for preterm and any-onset PE using different biomarker combinations was quantified by area under the receiver-operating-characteristics curve (AUC) and detection rate (DR) at a 10% fixed false-positive rate (FPR). Differences in AUC between biomarker combinations were compared using the DeLong test.Results The concordance correlation coefficient between ELISA and POC measurements was 0.86 (95% CI, 0.83-0.88). Passing-Bablok analysis indicated proportional bias (slope, 1.08 (95% CI, 1.04-1.14)), with POC GlyFn being significantly higher compared with ELISA GlyFn. ELISA GlyFn in non-PE pregnancies was independent of gestational age at screening (P = 0.11), but significantly dependent on maternal age (P < 0.003), weight (P < 0.0002), height (P = 0.001), parity (P < 0.02) and smoking status (P = 0.002). Compared with non-PE pregnancies, median GlyFn MoM using ELISA and POC testing was elevated significantly in those with preterm PE (1.23 vs 1.00; P < 0.0001 and 1.18 vs 1.00; P < 0.0001, respectively) and those with term PE (1.26 vs 1.00; P < 0.0001 and 1.22 vs 1.00; P < 0.0001, respectively). GlyFn MoM was not correlated with gestational age at delivery with PE (P = 0.989). Adding GlyFn to the FMF triple test for preterm PE increased significantly the AUC from 0.859 to 0.896 (P = 0.012) and increased the DR at 10% FPR from 64.9% (95% CI, 48.7-81.1%) to 82.9% (95% CI, 66.4-93.4%). The corresponding DRs at 10% FPR for any-onset PE were 52.5% (95% CI, 42.3-62.5%) and 65.4% (95% CI, 55.2-74.5%), respectively.Conclusions Adding GlyFn to the FMF triple test increased the screening sensitivity for both preterm and any-onset PE in an Asian population. Prospective non-intervention studies are needed to confirm these initial findings. (c) 2023 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
收藏
页码:512 / 521
页数:10
相关论文
共 40 条
  • [1] Glycosylated fibronectin as a first trimester marker for gestational diabetes
    Alanen, Julia
    Appelblom, Heidi
    Korpimaki, Teemu
    Kouru, Heikki
    Sairanen, Mikko
    Gissler, Mika
    Ryynanen, Markku
    Nevalainen, Jaana
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2020, 302 (04) : 853 - 860
  • [2] BABLOK W, 1988, J CLIN CHEM CLIN BIO, V26, P783
  • [3] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [4] Hypertensive Disorders of Pregnancy ISSHP Classification, Diagnosis, and Management Recommendations for International Practice
    Brown, Mark A.
    Magee, Laura A.
    Kenny, Louise C.
    Karumanchi, S. Ananth
    McCarthy, Fergus P.
    Saito, Shigeru
    Hall, David R.
    Warren, Charlotte E.
    Adoyi, Gloria
    Ishaku, Salisu
    [J]. HYPERTENSION, 2018, 72 (01) : 24 - 43
  • [5] Association between gestational diabetes and pregnancy-induced hypertension
    Bryson, CL
    Ioannou, GN
    Rulyak, SJ
    Critchlow, C
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2003, 158 (12) : 1148 - 1153
  • [6] First-trimester pre-eclampsia biomarker profiles in Asian population: multicenter cohort study
    Chaemsaithong, P.
    Sahota, D.
    Pooh, R. K.
    Zheng, M.
    Ma, R.
    Chaiyasit, N.
    Koide, K.
    Shaw, S. W.
    Seshadri, S.
    Choolani, M.
    Panchalee, T.
    Yapan, P.
    Sim, W. S.
    Sekizawa, A.
    Hu, Y.
    Shiozaki, A.
    Saito, S.
    Leung, T. Y.
    Poon, L. C.
    [J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2020, 56 (02) : 206 - 214
  • [7] First trimester preeclampsia screening and prediction
    Chaemsaithong, Piya
    Sahota, Daljit Singh
    Poon, Liona C.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (02) : S1071 - +
  • [8] Prospective evaluation of screening performance of first-trimester prediction models for preterm preeclampsia in an Asian population
    Chaemsaithong, Piya
    Pooh, Ritsuko K.
    Zheng, Mingming
    Ma, Runmei
    Chaiyasit, Noppadol
    Tokunaka, Mayumi
    Shaw, Steven W.
    Seshadri, Suresh
    Choolani, Mahesh
    Wataganara, Tuangsit
    Yeo, George S. H.
    Wright, Alan
    Leung, Wing Cheong
    Sekizawa, Akihiko
    Hu, Yali
    Naruse, Katsuhiko
    Saito, Shigeru
    Sahota, Daljit
    Leung, Tak Yeung
    Poon, Liona C.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2019, 221 (06)
  • [9] Prospective Evaluation of International Prediction of Pregnancy Complications Collaborative Network Models for Prediction of Preeclampsia: Role of Serum sFlt-1 at 11-13 Weeks' Gestation
    Chaiyasit, Noppadol
    Sahota, Daljit S.
    Ma, Runmei
    Choolani, Mahesh
    Wataganara, Tuangsit
    Sim, Wen Shan
    Chaemsaithong, Piya
    Wah, Yi Man Isabella
    Hui, Shuk Yi Annie
    Poon, Liona C.
    [J]. HYPERTENSION, 2022, 79 (02) : 314 - 322
  • [10] Fibronectin Is an Important Regulator of Flow-Induced Vascular Remodeling
    Chiang, Hou-Yu
    Korshunov, Vyacheslav A.
    Serour, Andrew
    Shi, Feng
    Sottile, Jane
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2009, 29 (07) : 1074 - U157